Aclaris Therapeutics, Inc. ACRS
4.24 USD +0.34 (+8.72%)
At closeNov 10, 2026, 5:32 AM EST
4.05 -0.19 -4.50%
Pre-market · Nov 10, 5:32 AM ET
3.85 Day range 4.30
2.10 52-week range 6.60
- YTD
- +40.86%
- 1 year
- +82.76%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 7.83M | 18.72M | 31.25M | 29.75M | 6.76M | |
| 542.00K | 3.26M | 13.17M | 17.79M | 2.05M | |
| -74.08M | -139.43M | -124.26M | -85.15M | -65.38M | |
| -64.92M | -132.06M | -88.48M | -86.91M | -90.86M | |
| -0.53 | -1.71 | -1.27 | -1.33 | -1.60 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 19.96M | 24.57M | 39.88M | 45.28M | 27.35M | |
| 160.46M | 220.33M | 197.41M | 254.60M | 251.21M | |
| 57.38M | 64.77M | 40.23M | 56.98M | 53.87M | |
| 103.08M | 155.55M | 157.18M | 197.62M | 197.34M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -47.11M | -20.07M | -78.33M | -67.57M | -52.13M | |
| 48.37M | -69.77M | 46.22M | 12.63M | -167.63M | |
| -5.86M | 74.54M | 26.71M | 72.87M | 225.05M | |
| -111.00K | -121.00K | -1.31M | -605.00K | -308.00K | |
| -4.61M | -15.31M | -5.40M | 17.93M | 5.29M |